Skip to content

Pricing Sign in

Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act)

It became law on May 16, 2022.

MD HB 1397 · House Bill · 2022

Stage: Became law
Started in: House
Sponsors: 31
Latest action: May 16, 2022

Where it stands

Introduced (Done)
Committee (Done)
Floor (Done)
Law (Done)
May 16, 2022

This bill passed and is now law.

Read the full text

What moved

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

Alfred C. Carr, Jr.Lead sponsor
Anne KaiserLead sponsor
Ariana KellyLead sponsor
Ben BarnesLead sponsor
Bonnie CullisonLead sponsor
Brian ChisholmLead sponsor
Cheryl Summers LandisLead sponsor
Faye Martin HowellLead sponsor
Geraldine Valentino-SmithLead sponsor
Harry BhandariLead sponsor
Heather Bagnall TudballLead sponsor
Joseline Peña-MelnykLead sponsor
Karen YoungLead sponsor
Kathy SzeligaLead sponsor
Ken KerrLead sponsor
Kirill ReznikLead sponsor
Kris ValderramaLead sponsor
Mary LehmanLead sponsor
Matt MorganLead sponsor
Ned CareyLead sponsor
Nic KipkeLead sponsor
Nick CharlesLead sponsor
Robbyn LewisLead sponsor
Sandy RosenbergLead sponsor
Shane E. PendergrassLead sponsor
Shaneka HensonLead sponsor
Sheree Sample-HughesLead sponsor
Sid SaabLead sponsor
Steve JohnsonLead sponsor
Teresa ReillyLead sponsor
Terri HillLead sponsor

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

Once a bill is decided, the questions are about what is done with it in Maryland.

What an agency writes to carry it outAn agency's name on a lobbying report is not a rulemaking.
Which court can stay or strike itAn opinion listed here is not yet tied to the law it reviewed.
How the place it governs is doingBecoming law is not the result. A number moving is not proof the law moved it.

Work with this bill

Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act) | 52